The Ethical and Versatile Potential of Induced Pluripotent Stem Cells (iPSCs)Boston, Jan. 22, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Induced Pluripotent Stem Cells: ...

Creative Biolabs Backed by a team of talented scientists and advanced platforms, Creative Biolabs provides a series of solutions to support ...

In several pre-clinical studies, iPSC-derived cardiomyocytes have been shown to improve heart function. The LAPiS study is a 52-week, phase 1/2, open-label, dose-escalation study conducted at ...

The industry-trusted 2nd iPSC-Derived Cell Therapies Summit provides a dedicated forum to voice challenges, collaborate and spark conversations with the community committed to advancing iPSC ...

9–11 The iPSC-CM disease model allows the concept of ‘personalised medicine’ to ... One of the first major reports on the use of stem cells for biological pacing involved the implantation of ...

Newly generated human embryonic stem cell‐derived atrial‐like cardiomyocytes resemble human atrial cardiomyocytes and prove to be a valuable model for pre‐clinical drug screenings to identify ...

Human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CM) have shown potential to identify delayed responses, reveal patient-specific susceptibilities, and detect some off-target effects.

Human iPSC-based modeling using microglia-containing long-term adhesion brain organoids reveals the role of microglia in supporting neuronal growth and function, as well as protecting neurons from ...